Developement of a process end point monitor for lyophilized biologic drugs for cancer treatment
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200622021C
- Awardee
-
Physical Sciences Inc. UEI RMG1AZ1ZH8Q7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $99,995
Award facts
- Contract value 33% obligated
- $299,985.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Andover, MA 01810, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $99,995 |
About this award
This federal contract award was made by a U.S. government agency to Physical Sciences Inc. (PSI), a for-profit research and development company. The contract is for the development of a process end point monitor for lyophilized biologic drugs for cancer treatment, under the Small Business Innovation Research (SBIR) Phase I program. The contract is a definitive, firm-fixed-price contract with a ceiling value of $299,985.00. The place of performance is Andover, MA. PSI is an experienced government contractor, having supported various federal agencies such as the Department of Defense, NASA, Department of Energy, and National Institutes of Health through both contract and grant awards. The company specializes in advanced materials, optical systems, radiation detection technologies, and specialized instrumentation. This contract award is part of the agency's efforts to develop innovative technologies for cancer treatment using lyophilized biologic drugs.
Quick answers
Who was awarded contract HHSN261200622021C?
HHSN261200622021C was awarded to Physical Sciences Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2006.
How much is contract HHSN261200622021C worth?
The government has obligated $99,995 on HHSN261200622021C. Its current value, with exercised options, is $299,985.
Was contract HHSN261200622021C competed?
The extent of competition for HHSN261200622021C was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award